LORAIN, Ohio, March 21, 2012 /PRNewswire-USNewswire/ -- The Innovation Fund, founded by

CLEVELAND, July 20, 2011 /PRNewswire/ -- Arteriocyte®, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies announced today that the Ohio Department of Development's Third Frontier Commission awarded a $1 million grant to the company for its "Development and Commercialization of Hematopoietic Stem Cell Expansion for Clinical Applications" as part of the Ohio Third Frontier Biomedical Program to accelerate the company's Good Manufacturing Practices (GMP) manufacturing of its NANEX(TM) technology for clinical use under the product name HemaEx. (Logo: http://photos.prnewswire.com/prnh/20100624/ALOGO ) The NANEX(TM) technology is a biofunctional nanofiber-based 3D scaffold designed to mimic the bone marrow environment, permitting rapid ex vivo proliferation of hematopoietic stem cells with minimal differentiation.

COLUMBUS, Ohio, July 14, 2011 /PRNewswire/ -- Business owners striving to launch and grow in the solar industry are easily drawn to locations that boast their desire and willingness to nurture invention.

HARRISBURG, Pa., Jan. 28, 2011 /PRNewswire-USNewswire/ -- New state investments in Pennsylvania's technology sector will help bring innovative products to the marketplace and strengthen Pennsylvania's energy industry, Department of Community and Economic Development acting Secretary C.

COLUMBUS, Ohio, Dec. 8, 2010 /PRNewswire/ -- Ohio Third Frontier and numerous related technology-based economic development programs in Ohio have had a hand in the success of nearly two-dozen of the Inc. 5000 fastest-growing, private companies in America.